A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism (Q78092463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

1 reference

J Schmider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

H Standhart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M Deuschle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J Drancoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

I Heuser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

437-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Visual analog scale for the assessment of total hip arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

A pictorial visual analog scale for rating severity of childhood asthma episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

7 January 2021

The catatonic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Clinical Pharmacokinetics of Oxazepam and Lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Treatment of catatonia with low-dose lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Lorazepam for a short-term alleviation of mutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Reproducibility of visual analog scale measurements of dyspnea in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

A proposal to use confidence intervals for visual analog scale data for pain measurement to determine clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

7 January 2021

Diazepam for catatonia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

The Visual Analog Scale in Multiple-Dose Evaluations of Analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Psychogenic catatonia treated with lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Lorazepam for psychogenic catatonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Use of benzodiazepines in anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Catatonia relieved by oral diazepam in a patient with a pituitary microadenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Lorazepam monotherapy for catatonic stupor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Lorazepam for treatment of catatonic symptoms and severe psychomotor retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Benzodiazepines for catatonic symptoms, stupor, and mutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Comparison of sublingual lorazepam with intramuscular diazepam as sedatives during oral surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

Benzodiazepine-induced hypomania?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900312-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(98)00312-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10435212%20AND%20SRC:MED&resulttype=core&format=json